Perspective Therapeutics (CATX) Free Cash Flow (2016 - 2026)

Perspective Therapeutics' Free Cash Flow history spans 17 years, with the latest figure at -$31.5 million for Q1 2026.

  • On a quarterly basis, Free Cash Flow fell 45.75% to -$31.5 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$92.5 million, a 14.47% increase, with the full-year FY2025 number at -$82.6 million, down 13.63% from a year prior.
  • Free Cash Flow hit -$31.5 million in Q1 2026 for Perspective Therapeutics, down from -$24.7 million in the prior quarter.
  • Over the last five years, Free Cash Flow for CATX hit a ceiling of $13.8 million in Q1 2024 and a floor of -$81.0 million in Q4 2024.
  • Historically, Free Cash Flow has averaged -$14.0 million across 5 years, with a median of -$9.9 million in 2023.
  • The widest YoY moves for Free Cash Flow: up 239.54% in 2024, down 790.36% in 2024.
  • Tracing CATX's Free Cash Flow over 5 years: stood at -$6.2 million in 2022, then crashed by 45.86% to -$9.1 million in 2023, then crashed by 790.36% to -$81.0 million in 2024, then soared by 69.49% to -$24.7 million in 2025, then fell by 27.36% to -$31.5 million in 2026.
  • Business Quant data shows Free Cash Flow for CATX at -$31.5 million in Q1 2026, -$24.7 million in Q4 2025, and -$16.3 million in Q3 2025.